Taiyo Generic Drug Factory Ordered To Halt Operation
This article was originally published in PharmAsia News
Executive SummaryNagoya-based Taiyo Pharmaceutical's generic drug plant was ordered to halt production for 10 days
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.